philanthropy.org | 990 Resource | FAQ Verify yourself Sign in
MP
Person · officer / director

Michael P Boyle MD

President & CEO · Cystic Fibrosis Foundation

President & CEO at Cystic Fibrosis Foundation. Listed as an officer, director, or key employee across 2 organizations on the Form 990 record.

Organizations
2
Roles reported
2
Reported compensation
$1.1M

Who this is

Profile

Everything on the left is verified from the IRS filings. The biography on the right is compiled from public web sources and grounded to that filed record.

✓ Verified from filings
●
Reported as President & CEO of Cystic Fibrosis Foundation, based in Bethesda, MD.
●
Received $1.1M in total reported compensation on the most recent Form 990 (Part VII).
●
Also listed as President/Director of Cystic Fibrosis Foundation Therapeutics INC, uncompensated.
Facts extracted directly from each organization's Form 990, Part VII.
Biography Web-sourced

Michael P. Boyle, MD is President and Chief Executive Officer of the Cystic Fibrosis Foundation, where he leads the organization's therapeutic development strategy.

As an internationally recognized clinical researcher, he founded and directed the Johns Hopkins Adult Cystic Fibrosis Program for two decades and served as investigator in landmark clinical trials for Kalydeco and Orkambi, breakthrough CF treatments. He holds an adjunct professorship at Johns Hopkins University School of Medicine.

Compiled from public web sources (4 cited), grounded to the filed record.

Track record

Career & tenure

Real tenure, career, and education — from public web sources, what you need to vet a founder or leader beyond the filing window.

Tenure here
Current President & CEO; prior Senior Vice President of Therapeutics Development (2015-2019)
Education
  • Johns Hopkins University School of Medicine (adjunct professor)

Affiliations

Organizations

Linked as the same person by IRS Schedule R, a shared officer mailing address, or shared fellow board members.

Cystic Fibrosis Foundation President & CEO · $355.8M revenue · Bethesda, MDTO CURE CYSTIC FIBROSIS (CF) AND TO PROVIDE ALL PEOPLE WITH CF THE (CONTINUED ON SCH O) OPPORTUNITY TO LEAD LONG, FULFILLING LIVES.pay $819K → $1.1MFiled FY2024, FY2023, FY2022, FY2021, FY2020 · Source: Form 990, Part VII
$1.1Mreported comp
Cystic Fibrosis Foundation Therapeutics INC President/Director · Bethesda, MDFiled FY2024, FY2023, FY2022 · Source: Form 990, Part VII

Network

Serves alongside

Other officers, directors & key employees at this person's organizations, by latest reported compensation.

J
Chief Investment Officer · FY2023
$2.7M
J
Chief Investment Officer · FY2022
$2.5M
J
Chief Investment Officer · FY2024
$1.9M
A
Managing Director, Investments · FY2024
$1.4M
E
Managing Director, Investments · FY2024
$1.2M
E
Managing Director, Investments · FY2022
$1.0M
E
Managing Director, Investments · FY2024
$976K
I
EVP & Chief Operating & Financial Officer · FY2024
$762K
J
SVP, Clinical Research · FY2024
$670K
G
Managing Director, Investments Operations · FY2024
$643K
A
VP, Clinical Development · FY2022
$574K
A
Chief Medical Officer Beg. 7/1/2024 · FY2024
$572K

Network

Recommendations

Written by other verified members of the network — visible once you're a verified person yourself.

Loading…

Explore

Similar organizations

Nonprofits working in the same field — explore who else operates in this space.

World Federation of Hemophilia USA$1.1B revenue · Albany, NY
United Cerebral Palsy of New York City INC$242.7M revenue · New York, NY
C
Center for Disability Services INC$125.8M revenue · Albany, NY
Upstate Cerebral Palsy INC$124.6M revenue · Utica, NY
March of Dimes INC$83.6M revenue · Arlington, VA

People like this

Similar leaders

Leaders at organizations in the same field, by reported compensation.

L
Physician · Boston Pediatric Neurosurgical Foundation INC
$4.8M
N
CEO · American Heart Association INC
$4.5M
R
Director/Chair/Pres/CEO · Stowers Resource Management INC
$3.0M
J
Chief Investment Officer · Cystic Fibrosis Foundation
$2.7M
J
Chief Investment Officer · Cystic Fibrosis Foundation
$2.5M
B
Medical Oncology · Central Arkansas Radiation Therapy
$2.1M
Public data from IRS Form 990 e-file & the Business Master File. Individuals appear here because they were named as an officer, director, or key employee on a nonprofit's Form 990; people are grouped by name plus corroborating evidence (Schedule R, shared address, shared board members). · philanthropy.org